Kazia Therapeutics Ltd. KZIA
What this company does
Written from the business description in Kazia Therapeutics Limited's annual report to the U.S. Securities and Exchange Commission, filed 7 November 2025. Every sentence was checked against that document before publication.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue AUD B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 |
| Operating income AUD B | · | · | · | · | · | · | · | · | · | · |
| EBITDA AUD B | · | · | · | · | · | · | · | · | · | · |
| Income tax AUD B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | · |
| Net income AUD B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow AUD B | · | · | · | · | · | · | · | · | −0.0 | −0.0 |
| EPS, diluted AUD | −0.04 | −0.10 | −0.11 | −0.19 | −0.07 | −0.17 | −17.86 | −12.48 | −2.28 | −2.82 |
| Dividend / sh AUD | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · |
| ROE % | · | −2634.3 | −135.0 | −89.1 | −32.4 | −88.0 | −61.4 | −27.1 | −42.1 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Reconciled in 6 of 19 fiscal years. 39 checks could not be computed.